Orange Book product · Generic (ANDA)
CAFFEINE CITRATE
CAFFEINE CITRATE
At a glance
Sep 30, 2009
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 30, 2009
17 yr ago
Today
Pharmaceutical detail
Active ingredient
CAFFEINE CITRATE
Strength
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
ANDA 090357
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CAFFEINE CITRATE
- 1999CAFCITBrand (NDA)
NDA 020793 · HIKMA
- 2019CAFFEINE CITRATEGeneric (ANDA)
ANDA 213202 · MICRO LABS
- 2017CAFFEINE CITRATEGeneric (ANDA)
ANDA 207400 · MICRO LABS
- 2015CAFFEINE CITRATEGeneric (ANDA)
ANDA 205013 · EUGIA PHARMA
- 2012CAFFEINE CITRATEGeneric (ANDA)
ANDA 090827 · SAGENT PHARMS
- 2012CAFFEINE CITRATEGeneric (ANDA)
ANDA 091102 · SAGENT PHARMS
- 2009CAFFEINE CITRATEGeneric (ANDA)
ANDA 090064 · AM REGENT
- 2009CAFFEINE CITRATEGeneric (ANDA)
ANDA 090077 · SUN PHARM
- 2008CAFFEINE CITRATEGeneric (ANDA)
ANDA 078002 · FRESENIUS KABI USA
- 2007CAFFEINE CITRATEGeneric (ANDA)
ANDA 077997 · FRESENIUS KABI USA
- 2007CAFFEINE CITRATEGeneric (ANDA)
ANDA 077906 · AM REGENT
- 2006CAFFEINE CITRATEGeneric (ANDA)
ANDA 077233 · EXELA PHARMA SCIENCE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
